Subscribe To
Arbutus presents preliminary ab-729 and pegylated interferon alfa-2a combination data at the easl congress 2023
Treatment was generally well tolerated with continued HBsAg declines in some patients WARMINSTER, Pa., June 21, 2023 (GLOBE NEWSWIRE) — Arbutus Biop...
June 21, 2023, 6:01 am